New advances in the diagnosis and treatment of ocular rosacea
10.3760/cma.j.cn115989-20241104-00304
- VernacularTitle:眼红斑痤疮诊疗的新进展
- Author:
Xiaoxiao ZHANG
1
;
Lin DING
1
Author Information
1. 新疆维吾尔自治区人民医院眼科医学诊疗中心，乌鲁木齐 830001
- Publication Type:Journal Article
- Keywords:
Ocular rosacea;
Meibomian gland dysfunction;
Doxycycline;
Intense pulsed light;
Children
- From:
Chinese Journal of Experimental Ophthalmology
2025;43(5):484-488
- CountryChina
- Language:Chinese
-
Abstract:
Ocular rosacea is a chronic inflammatory disease that primarily affects the ocular surface and is often delayed in diagnosis due to the absence of skin symptoms.Studies have shown that 58.0% of patients with rosacea may present with ocular rosacea.At present, the pathogenesis of ocular rosacea is mainly related to immune dysregulation and Demodex mite infection.Common ocular features include meibomian gland dysfunction with recurrent styes, chronic blepharitis, diffuse congestive conjunctivitis, episcleritis, anterior uveitis and, rarely, corneal ulcers or even corneal perforation.Commonly used treatments such as physiotherapy, medication, laser therapy, etc.can significantly improve symptoms and protect vision, and patients with perforation may be considered for surgery.This article reviews the epidemiology, pathogenesis, clinical features, diagnosis, and treatment of ocular rosacea and suggests possible future therapeutic drug targets to provide more effective treatment options in the future in the future.
